COVID-19 vaccine makers exploring if omicron versions of shots are needed

Officials from Moderna and Pfizer are assessing their responses to the new COVID-19 variant omicron and say it will take months to develop a tweaked shot if needed.

Dallas clinics expect increase in booster demand due to new COVID-19 omicron variant

Dallas-based clinics expect an increase in booster demand over the next few weeks with questions swirling around the new COIVD-19 omicron variant. Pharmacists assure there isn't a supply issue even though they're going through vaccines faster.

Supply chain challenges continue for North Texas small businesses

President Biden reported the number of shipping containers sitting for more than eight days is down by more than 40% this month. But that is trickling down slowly to small businesses.

Omicron variant: CDC expands COVID-19 booster recommendation to all adults 18 and older

"Everyone ages 18 and older should get a booster shot either when they are 6 months after their initial Pfizer or Moderna series or 2 months after their initial J&J vaccine," the U.S. Centers for Disease Control and Prevention said.

Dallas County judges get more flexibility on COVID-19 courtroom protocols

Judge Maricela Moore, tasked with making COVID-19 protocols, has updated operating guidance that gives both civil and criminal district judges more latitude in use of their courtrooms.

Omicron variant prompts new U.S. travel restrictions starting Monday

The United States has imposed new travel restrictions hoping to keep out a new strain of the coronavirus. But some experts say it may already be too late.

Omicron shows need for global accord on pandemics, WHO chief says

The WHO is pushing for an international accord to help prevent future pandemics amid the emergence of the new omicron COVID-19 variant.

Young COVID-19 ‘long haulers’ promote vaccine in new ad campaign

“I have a lot of debilitating nausea, dizziness and a racing heart. I can't comprehend words at times,” 26-year old Isiah said in one video after getting COVID-19 in October 2020.

Omicron variant: World races to contain new 'highly transmissible' COVID-19 strain

The world is racing to contain a new coronavirus variant that is potentially more dangerous than the one that has fueled waves of infection on nearly every continent.

US, Canada, EU, Japan restrict South Africa travel over Omicron variant

Advisers to the World Health Organization held a special session Friday to flesh out information about the worrying new variant of the coronavirus that has been detected in South Africa.

North Texas Black Friday shoppers see some higher prices, empty shelves

The day after Thanksgiving typically marks the unofficial beginning of the holiday shopping season, but stores in recent years have put less emphasis on it. This year, many may see higher prices and empty shelves due to the supply chain crisis.

Moderna testing 3 COVID-19 booster vaccines on omicron variant, Pfizer ready to adapt

Pfizer said if any coronavirus variant ever evades the protection offered by its COVID-19 vaccine, it expects to be able to produce a “tailor-made” adapted version of its vaccine to fight that variant in approximately 100 days, pending approval from federal regulators.

Will travel bans stop 'highly transmissible' omicron variant?

A coronavirus variant recently identified in South Africa is leading to a new round of travel restrictions just as many had finally begun to ease.

Omicron variant: What to know about the new COVID-19 strain

South African scientists identified a new version of the coronavirus this week that they say is behind a recent spike in COVID-19 infections in Gauteng, the country’s most populous province.

Omicron variant: WHO says new COVID-19 strain shows increased reinfection risk

The World Health Organization called a special session to flesh out information about a worrying new variant of the coronavirus that has been detected in South Africa.

Stocks sink on new COVID variant; Dow loses 1,000 points

A day after the Stock Market was closed for Thanksgiving, news of a new COVID-19 variant sent stocks falling, with the Dow losing 1,000 points.

FDA finds Merck COVID-19 pill effective, seeks outside experts on safety

U.S. health officials say Merck's experimental COVID-19 pill is effective but they raised questions about its safety during pregnancy.